Trial
NCT05220397
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Mark Stegall
Collaborators
Janssen Scientific Affairs, LLC
Condition
Kidney Transplant Recipient
Intervention
Janssen Ad26.CoV2.S Vaccine
Why stopped
Janssen Biotech, Inc stopped production of the vaccine, and it was no longer available as of 2023.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-15